Skip to content

The clinical study of the integrated therapy of Chinese and Western medicine in the treatment of new coronary virus infection and the laws of Chinese medicine syndrome

The clinical study of the integrated therapy of Chinese and Western medicine in the treatment of new coronary virus infection and the laws of Chinese medicine syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072959
Enrollment
Unknown
Registered
2023-06-28
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New coronary virus infection

Interventions

Chinese medicine treatment group:N/A
Non -Chinese Medicine Treatment Group:N/A

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. The diagnostic criteria that meets the new type of coronary virus infection or severe type; Western medicine diagnosis standard refer to the "New Coronatte Virus Infection Diagnosis Plan" (Trial Tenth Edition) 1) Heavy type: Adults are in line with any of the following and cannot be explained other than the new coronal virus infection: ? There is shortness of breath, RR = 30 times/minute; ? In a static state, the oxygen saturation is =93%when sucking the air; ? Arterial blood oxygen division (PAO2)/Oxygen concentration (FIO2) =300mmHg (1mmHg = 0.133kPa), high altitude (more than 1,000 meters above sea level) should be corrected to PAO2/FIO2 according to the following formulas: PAO2/FIO2 × [[FIO2 × [ 760/atmospheric pressure (mmHg)]; ? The clinical symptoms are aggravated, and the lung imaging science shows that the lesions have made significant progress in 24 to 48 hours. 2) Dangerous type: One of the following situations: ? respiratory failure occurs, and mechanical ventilation is required; ? Park; ? Combined other organ failure requires ICU monitoring treatment. 2. Age =14 years old, gender is not limited; 3. Patients accept this study and agree to sign the informed consent, who can cooperate on time.

Exclusion criteria

Exclusion criteria: 1. Women during pregnancy or lactation; 2. From November 2022 to January 2023, he participated in other patients with clinical trials.

Design outcomes

Primary

MeasureTime frame
Hospitalization time;The ratio of the intensive care unit;New crown virus nucleic acid turns overcast time;Clinical symptoms to relieve time;Antibiotic medication time;Hormone use ratio;The proportion of sequelae of new coronary virus infection;

Secondary

MeasureTime frame
WBC;Ultra -sensitive C reactive protein;Chest CT;Oxygen saturation;Muscle Calcin I;CKMB;Myoglobin;proBNP;ECG;Coagulation;HbA1c;

Countries

China

Contacts

Public ContactZhou Jin

Shenzhen Second People's Hospital

2993754876@qq.com+86 138 2376 6092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026